Medical Articles 5/22

Posted by rob on May 22, 2008 under Uncategorized | Be the First to Comment

Human
flt3 is expressed at the hematopoietic stem cell and the
granulocyte/macrophage progenitor stages to maintain cell survival.

Once
daily iv busulfan and fludarabine (iv Bu-Flu) compares favorably with
iv busulfan and cyclophosphamide (iv BuCy2) as pretransplant
conditioning therapy in AML/MDS.

Long-term
follow-up of allogeneic hematopoietic stem cell transplantation for de
novo acute myelogenous leukemia with a conditioning regimen of total
body irradiation and granulocyte colony-stimulating factor-combined
high-dose cytarabine.

HLA-haploidentical
bone marrow transplantation for hematologic malignancies using
nonmyeloablative conditioning and high-dose, posttransplantation
cyclophosphamide.

High-risk acute lymphoblastic leukemia cells with bcr-abl and INK4A/ARF mutations retain susceptibility to alloreactive T cells.

Individual physician practice variation in hematopoietic cell transplantation.

Altered phenotype of natural killer cell subsets after haploidentical stem cell transplantation.

Rituximab associated to imatinib for coexisting therapy-related chronic myeloid leukaemia and relapsed non-Hodgkin lymphoma.

Imatinib
mesylate therapy in chronic myeloid leukemia patients in stable
complete cytogenic response after interferon-alpha results in a very
high complete molecular response rate.

Add A Comment

You must be logged in to post a comment.

home top